Skip to content

Acadia Healthcare ACHC Redeemable NCI

Redeemable NCI at other companies

Encompass Health Corporation logo
Encompass Health CorporationEHC
$58.8M+4.8%
Select Medical Holdings logo
Select Medical HoldingsSEM
$20.97M+132%
Tenet Healthcare logo
Tenet HealthcareTHC
$2.14B-23.0%
Healthpeak Properties logo
Healthpeak PropertiesDOC
$27.21M+88.8%
Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
$21.76M+16.9%

Other financials

Income statement

See full
Revenue$828.8M+7.6%
Net income$4.1M-51.0%
EPS (diluted)$0.05-44.4%

Balance sheet

See full
Cash & equivalents$158.5M+73.7%
Total debt$2.7B+14.7%
Total equity$2.0B-35.6%
Total assets$5.5B-9.8%

Cash flow

See full
Operating cash flow$61.5M+436%
CapEx$76.6M-56.2%
Free cash flow-$15.0M+90.8%

Valuation

See full
Market cap$2.26B-23.6%
Enterprise value$4.77B-7.7%
P/S0.7×-0.3×

Profitability

See full
Net margin-32.8%-38.8pp
FCF margin-8.7%-0.1pp

Returns & leverage

See full
Return on equity-44.3%-50.6pp
Debt / equity1.4×+0.6×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Acadia Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.

The official record: Acadia Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Healthcare's redeemable nci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Healthcare's redeemable NCI?
Acadia Healthcare (ACHC) reported redeemable NCI of $209.98M in Q1 2026.
How has Acadia Healthcare's redeemable NCI changed year-over-year?
Acadia Healthcare's redeemable NCI increased by 58.6% year-over-year, from $132.42M to $209.98M.
What is the long-term trend for Acadia Healthcare's redeemable NCI?
Over 5 years (2020 to 2025), Acadia Healthcare's redeemable NCI has grown at a 28.2% compound annual growth rate (CAGR), from $55.32M to $191.59M.
What does redeemable NCI mean?
Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.